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Background
Upon expression, the Gag polyprotein of HIV-1 sponta-
neously assembles giving rise to enveloped virus-like
particles (VLPs). These particulate immunogens offer
great promise as HIV-1 vaccines. In order to develop
robust VLP manufacturing processes, the availability of
simple, fast and reliable quantitation tools is crucial.
Traditionally, commercial p24 ELISA kits are used to
estimate Gag VLP concentrations. However, this quanti-
tation technique is time-consuming, laborious, costly
and prone to methodological variability. Reporter pro-
teins are frequently used during process development to
allow a straightforward monitoring and quantitation of
labeled products. This alternative was evaluated in the
present work by using a Gag-GFP fusion construct.
Materials and methods
Generation of fluorescent VLPs was carried out by tran-
sient transfection of HEK 293 suspension cells with a
plasmid coding for Gag fused to GFP (NIH AIDS
Reagent Program). VLP budding from producer cells
was visualized by electron microscopy (JEM-1400, Jeol)
and confocal fluorescence microscopy (Fluoview®
FV1000, Olympus, Japan). A purified standard of Gag-
GFP VLP material was obtained by ultracentrifugation
through a sucrose cushion and fully characterized. SDS-
PAGE, Western blot, size-exclusion chromatography
(SEC), nanoparticle tracking analysis (NTA, NanoSight®,
UK) and transmission electron microscopy (TEM) were
used for VLP characterization. The standard VLP mate-
rial was used for the development and validation of a
Gag-GFP VLP quantitation technique based on fluores-
cence. Viral particle titers estimated using this method
were compared with those obtained by p24 ELISA
(Innotest®, Innogenetics, Belgium), densitometry, TEM
and NTA.
Results
Upon transfection, Gag-GFP was expressed in the cyto-
plasm of the producer cells and accumulated in the
vicinity of the plasma membrane where the budding pro-
cess takes place. Upon staining with Cell Mask™, co-
localization of green (Gag-GFP molecules) and red (lipid
membrane) fluorescence was observed in yellow (Figure
1A). VLP budding was also visualized in TEM images of
ultrathin sections of HEK 293 producer cells (Figure 1B).
A purified Gag-GFP VLP standard material was
obtained by harvesting VLPs from cell culture superna-
tants of transfected HEK 293 cells by low speed centri-
fugation followed by VLP pelleting through a 30%
sucrose cushion. The purity of the standard material
was analyzed by SEC. The SEC chromatogram showed a
single peak eluting in the column void volume (V0 = 44
mL) as determined by UV and fluorescence analyses of
collected fractions (Figure 1D). The A260/A280 ratio
was 1.24 which is consistent with reported ratios for
purified retroviral particles [1]. The standard VLP mate-
rial was further characterized using different techniques.
Particle morphology was analyzed by TEM. Roughly
spherical viral particles surrounded by a lipid envelope
and containing an electro-dense core could be observed
(Figure 1C). The mean VLP diameter according to TEM
analysis was determined to be 141 ± 22 nm (n = 100),
which is the expected size of Gag-GFP VLPs as they
resemble immature HIV particles that are larger than
wild-type HIV-1 virions [2]. NTA analyses of the stan-
dard material showed that the most frequent particle
size value (statistical mode) was 149 ± 5 nm, which is
consistent with our TEM results. SDS-PAGE analysis of
the standard VLP material (Figure 1E) was performed.
Approximately, 65% of the total protein loaded in the
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gel corresponded to Gag-GFP (Figure 1E, full arrow),
the major HIV-1 VLP structural protein. The other
minor bands should correspond to cellular proteins
derived from host cells as retroviral particles are known
to promiscuously incorporate a significant amount of
host proteins [3,4]. A Gag-GFP band of the expected
molecular weight (~81 kDa) was specifically detected
using an anti-p24 mAb by Western blot analysis (Figure
1E, full arrow). The presence of a Gag-GFP fragment
(Figure 1E, empty arrow), representing only 5% of the
total Gag-GFP loaded, was also observed in the gel.
A fluorescence-based quantitation method for Gag-
GFP VLPs was developed [5]. Validation of the quantita-
tion assay was carried out according to International
Conference Harmonization (ICH) guidelines [6]. The
validation parameters evaluated included specificity, lin-
earity, quantitation range, limit of detection, precision,
and accuracy [5]. All validation parameters met the
criteria for analytical method validation. Some para-
meters were also studied in parallel for p24 ELISA for
comparison purposes (Table 1). Both techniques specifi-
cally detected Gag-GFP. Even though the p24 ELISA
assay showed to be more sensitive for Gag-GFP detec-
tion, the fluorescence-based method was more precise
and showed to be linear in a wider range. In addition,
the developed quantitation method required less time
and was considerably less expensive than the traditional
p24 ELISA method used for Gag VLP quantitation.
Finally, the standard VLP material was quantified using
several methods. In order to compare the concentration
of Gag-GFP in μg/mL as determined by the fluores-
cence-based method, ELISA and densitometry with the
titers obtained by TEM and NTA analyses which are
given in particles/mL, it was assumed that a Gag VLP
contains 2500 Gag molecules as previously reported [7].
All concentration values, regardless of the quantitation
Figure 1 Characterization of the purified standard Gag-GFP VLP material. (A) Confocal fluorescence microscopy image of a HEK 293
producer cell expressing green fluorescent Gag-GFP molecules. The lipid membrane is stained with Cell Mask™ (red) and the cell nucleus with
Hoechst (blue). (B) TEM image of an ultrathin section showing VLP budding from HEK 293 producer cells. (C) Negatively stained Gag-GFP VLPs
in the purified standard material. (D) Size exclusion chromatogram of the standard Gag-GFP VLP material. (E) SDS-PAGE and Western-blot
analyses of the standard VLP material. Full and empty arrows represent Gag-GFP protein and Gag-GFP fragment, respectively. Abbreviations: MW,
molecular weight standard.
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technique used, were in close agreement within an
expected range. These results support the reliability of
the fluorescence-based method developed [5].
Conclusions
Due to the flexibility of the retrovirus particle assembly
process, fluorescently tagged Gag VLPs can be easily gen-
erated by expressing Gag as a fusion construct with GFP.
Although fluorescently labeled Gag has mainly been used
to study retrovirus replication in living cells, this attractive
feature is exploited in our laboratory to facilitate the moni-
toring and quantitation of Gag VLPs. A purified standard
VLP material was obtained and fully characterized. VLPs
in the standard material showed to be of the expected size,
morphology and with a composition consistent with
immature HIV-1 particles. A fast, reliable and cost-effec-
tive quantitation method based on fluorescence was devel-
oped and validated using the standard VLP material. The
fluorescence-based quantification method should facilitate
the development and optimization of bioprocessing strate-
gies for Gag-based VLPs.
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Table 1 Comparison between the fluorescence-based





Specificity Gag-GFP fusion protein Gag-GFP fusion
protein
Linear range 7 to 1000 RFU
(10 to 3600 ng of p24/mL)
10 to 300 pg
of p24/mL
Precision ~2% CV ~10% CV
Limit of
detection
10 ng/mL of p24 10 pg/mL of p24
Time (96
samples)
~1.5 h ~4 h
Price (96
samples)
~10 € ~400 €
RFU: Relative fluorescence units
CV: Coefficient of variation
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